CancerVAX, Inc., developer of a breakthrough universal cancer vaccine that will use the body’s immune system to fight cancer, reported that CEO Ryan ...
Clinical trials recruited hundreds of thousands of patients, while families in lockdown waited, hoping for regulatory approval of a COVID-19 vaccine that w...
Relapsed or refractory precursor B-cell acute lymphoblastic leukemia Bleeding due to hemophilia A Non-small cell lung cancer Unresectable or metastati...
In the following decades, multiple classes and generations of antibiotics and other antimicrobials were discovered and developed. Following close behind we...
Survey of 7,000+ people in Asia shows expectation of early retirement, early deterioration in health Concerns about cost of well-being nu...
What are the major plans in store for the new APAC hub at Singapore? For a company like Abcam which strongly believes that collaboration is a big driver o...
The permanent shift in consumer preferences, rising expectations for enhanced customer experiences (CX) and digital transformation, driven by COVID-19, hav...
How do you foresee digitalisation trends in APAC pharmaceutical supply chain improvising visibility, agility, and business resilience? Unpredict...
What’s the way forward under extreme uncertainty? And how might the way be different for Asian companies? Christophe Weber, the CEO of Takeda Pharmac...
© 2024 Biopharma Boardroom. All Rights Reserved.
